ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2026
Stewardship in your pocket: launching Colorado's free antimicrobial mobile application.
Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim was to describe the development and implementation of Firstline (www.Firstline.org), a mobile antimicrobial stewardship (ASP) application (app) created to address barriers to robust ASP in Colorado hospitals. Design: A mixed-methods pragmatic implementation study using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework was conducted from October 2023-December 2025. Methods: ASP teams at Children's Hospital Colorado and Denver Health partnered with Firstline to develop the app using locally curated content. The app launched in October 2023 with a multifaceted dissemination campaign. Reach was assessed using geocoded user data. Effectiveness and adoption were evaluated using cross-sectional surveys at two time points. Implementation was characterized by analyzing utilization patterns. Maintenance was assessed by tracking monthly active users over two years. Results: Within the first year, 4,409 unique Colorado users downloaded the app, representing 15% of state clinicians (19% in Denver Metro; 5-17% in rural regions). Survey respondents (n = 215) reported high satisfaction: 63.9% and 72.9% found the app very easy to use, 71.3% and 83.2% reported enhanced antibiotic selection knowledge, and 100% advocated for ongoing support. Among respondents, 10% reported their facilities had formally adopted Firstline guidelines. The most frequently accessed content included common, high-impact infections. Monthly active users remained stable (average 871) over two years. Conclusions: We demonstrated use of Firstline across Colorado, with increasing engagement in rural areas. High user satisfaction, sustained engagement, and emerging institutional adoption suggest this "stewardship in your pocket" model offers a unique, scalable approach to extending ASP support beyond academic medical centers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.